Illoomee Pharmaceuticals Private Limited
About Illoomee Pharmaceuticals Private Limited
Data last updated:
Illoomee Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2019PTC344567.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Mohd Islam and Abdul Mustufa.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Hasan Ali H.No 146 Gali No.9 Mohan Baba Nagar Badarpur, New Delhi, Delhi, India – 110044.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Illoomee Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Hasan Ali H.No 146 Gali No.9 Mohan Baba Nagar Badarpur, New Delhi, Delhi, India – 110044
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Illoomee Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Illoomee Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Illoomee Pharmaceuticals Private Limited, buy the company report.
Board of directors of Illoomee Pharmaceuticals Private Limited
Illoomee Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Islam | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
| Abdul Mustufa | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Illoomee Pharmaceuticals Private Limited is audited by A VERMA & CO. for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A VERMA & CO. | FY 2020 | 025813C |
Shareholding
The shareholding of Illoomee Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Illoomee Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Illoomee Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Illoomee Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Illoomee Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Illoomee Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Abdul Mustufa was appointed as Director on 17 Jan 2019.
Frequently asked questions
Illoomee Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 January 2019 (7+ years old) and is registered under CIN U24239DL2019PTC344567.
Illoomee Pharmaceuticals has 2 current directors:
- Mohd Islam - Director
- Abdul Mustufa - Director
The latest financial statements of Illoomee Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Illoomee Pharmaceuticals is U24239DL2019PTC344567. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Illoomee Pharmaceuticals was incorporated on 17 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Abdul Mustufa was appointed as Director on 17 Jan 2019. Mohd Islam was appointed as Director on 17 Jan 2019.
The registered office of Illoomee Pharmaceuticals is at CO Hasan Ali H.No 146 Gali No.9 Mohan Baba Nagar Badarpur, New Delhi, Delhi, India – 110044.
Illoomee Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Illoomee Pharmaceuticals is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Illoomee Pharmaceuticals can be reached at its registered office: CO Hasan Ali H.No 146 Gali No.9 Mohan Baba Nagar Badarpur, New Delhi, Delhi, India – 110044.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
